AstraZeneca withdraws the Covid-19 vaccine worldwide: here's why
New variants, many vaccines available and increasingly low demand: AstraZeneca decides to withdraw the Vaxzevria vaccine
Updated anti-Covid vaccine, the campaign starts again: who can do it and when? Here is the latest news
The Ministry of Health has published the circular with the provisions on Covid and flu vaccination - It will officially start in October: here are all the details
Covid in recovery: today the green light for the vaccine. That's who has to do it
The new anti-Covid vaccines will arrive in October, but doubts remain about the adhesion of the population. The indications of the Ministry of Health
Covid, China still in the grip of the virus and stops publishing data: what is happening in the Asian giant
Catastrophic news has been arriving from China for days: hospitals and morgues are full and now the government will no longer communicate data on infections. Here's what's happening
Covid under the Christmas tree: growing infections, declining vaccinations, increasingly unclear information
The health picture detected by the Gimbe Foundation is worrying: woe to let your guard down in the face of the pandemic - "There is a widespread recovery of viral circulation, underestimated due to the widespread use of do-it-yourself tampons"
No Vax Covid doctors return to hospitals and stop vaccination of healthcare personnel: Government in the storm
Not a few controversies over the early reinstatement of no-vax doctors and the stop of vaccination of healthcare personnel - The anger of virologists, doctors, politicians and governors
Covid, reduced quarantine for asymptomatic from 7 to 5 days: here are the new rules
After the opinion of the Higher Health Council, the green light comes from the Ministry of Health: isolation is reduced for asymptomatic and long-term positives. Here's what changes
School and the new anti-Covid rules, from Dad to masks: the ministry's handbook
The text summarizes the documents prepared by the Istituto Superiore di Sanità in recent weeks, already sent to schools. Here are all the new rules for returning to class 2022
Novavax vaccine against Covid: green light in Europe for children between 12 and 17 years old
4 months after the first injections for Italian adults, the go-ahead from the European Commission for the Nuvaxovid anticovid vaccine for the 12-17 age group arrives
Mask obligation: remain for private work until June 30th
The obligation to wear a mask remains for the private sector, while in public offices it will only be recommended. Before June 30, a new comparison is expected for any updates
Covid, what changes from May XNUMXst? Goodbye to the Green pass but not to the masks indoors
While many anti-Covid measures, such as the Green Pass, will jump from May 1,2, there are still XNUMX million positive Italians. The rebus of indoor masks remains
fake news? In the Russia-Ukraine war they multiply, let us defend ourselves with a useful breviary
Are we prisoners of deception? It's not for sure. The weapons to verify and judge exist, starting right from the big network, the main vehicle of falsified news
Covid vaccine under 5: Pfizer asks the FDA for approval in the USA
In the US, the Pfizer vaccine for children under 5 could be available by the end of February - The dose will be one tenth of that expected for adults: 3 micrograms
Ema, green light to Novavax: it is the fifth anti-Covid vaccine in the EU
The European Medicines Agency gives the green light to the conditional marketing in the EU - Over 90% efficacy against the Alpha and Beta variants, little information on Omicron - Moderna: the third dose increases the antibodies against Omicron by 37 times
Bills, another billion from the Government to curb increases in 2022
The Council of Ministers has fired a new decree law with new fiscal measures containing advances on expenditure for 2021. For a total of 3,3 billion euros, of which 1,8 million for the purchase of vaccines
Super green pass from 6 December: when you need it and when the "basic" one is enough
The new rules come into force on December 6. What can vaccinated and healed do? What will be allowed with the swab alone? What about transport restrictions? Here are all the answers
BioNTech raises vaccine revenue estimates, record quarter
Thanks to third doses and the green light for the vaccine for the 5-11 age group, Pfizer and BioNTech will sell many more vaccines - Company raises guidance
J&J raises guidance: 500 million from vaccine sales
Revenues and profits up in the third quarter for the US pharmaceutical giant - 2021 billion in revenue from vaccine sales expected in 2,5
Third vaccine dose: green light from October for over 80s, RSA and health care
The new audience of 6 million people adds to the approximately 3 million immunocompromised patients who have started undergoing the booster dose since 20 September.
Biden, anti-Covid squeeze: mandatory vaccine for federal employees
the American president has decided to make it compulsory also for those who do business with the government - employees of companies that are entrusted with the contracts - without the alternative of the tampon anymore
Novavax: effective vaccine against variants, the title goes up
The US biotech company has announced the results of clinical trials that have reached phase 3 - The vaccine against the Covid-19 under investigation has a 93% efficacy against the most common variants
BioNTech: the vaccine makes revenues and profits fly, title in orbit
The title flies both in Frankfurt and on the Nasdaq - About 450 million doses delivered in 91 countries, in 2021 it will reach 1,8 billion - For the current year, revenues will exceed 12 billion
Vaccines over 50, reservations from May 10: here are the news
Bookings will be open from 10 May for those born up to 1971 - Figliuolo "Gradually opening, first people with pathologies or immunological impairment"
Pfizer, record revenues from vaccines: 26 billion in 2021
Pfizer sold vaccines worth 3,5 billion in the first quarter, estimates for 2021 rise from 15 to 26 billion - Revenues and earnings per share up sharply in the first three months of the year
Work: vaccination as an opportunity to trace the active population
The new way of measuring labor market stocks and flows introduced by the EU leads us to reflect on the real decline in jobs and not on the one masked by the abuse of social safety nets - An updated survey could…
AstraZeneca vaccine, Ema: "Rare links with thrombosis, but no restrictions"
The vaccine from the Anglo-Swedish company is safe, even if the EMA has added the very rare risk of thrombosis among the possible side effects. Women under 60 are more exposed, but there are no restrictions on administration.
Pfizer breakthrough: vaccine also effective for the 12-15 age group
The serum would protect adolescents even better than adults, with the same (minimal) side effects. Now the pharmaceutical company will send the results of the study to the FDA for the green light for administration.
Covid-19: guide to the new anti-contagion indications
Ministry of Health, ISS, Aifa and Inail have released a document containing anti-contagion indications - New recommendations on distance, quarantine and vaccines - Here is all the information
AstraZeneca, what happens after the stop? Here is all the information
What should those who already had a reservation do? And for the future? Here are all the doubts, risks and possible solutions, avoiding alarmism. Meanwhile Sweden, Slovenia and Portugal join the list of countries that have blocked via…
Covid vaccine: Johnson & Johnson is coming. Ok Ema by March 15th
The FDA has given the green light to the single-dose vaccine, now it's up to the EMA - Overall efficacy at 72%
Anti-Covid vaccine: which companies can produce it in Italy?
There are companies that can fill the whey, the problem is the bioreactors needed for production - Long times to organize and reconvert
Vaccines: AstraZeneca cuts deliveries again. The EU negotiates
The EU confirms the rumors of Reuters and asks for a new delivery plan from the Anglo-Swedish company. Italian government in the field
Astrazeneca doubles profits in the year of Covid
2020 Revenues Soar 9% to $26,6 Billion - 2021 Earnings Per Share Forecast Expected to Up to $4,75 to $5 $1,9 Dividend per Share - Stock…
Covid vaccine booking: where and how it can be done
Up until yesterday the procedure had only been activated in 5 Regions (including Lazio and Campania), but today three more should be added - Vaccination methods change according to the Region - Long times in Lombardy
Vaccine Moderna also distributed via Poste Italiane
The operation, which must comply with the rules of the cold chain, concerns another 66 thousand doses and will be carried out by the Sda courier
Covid vaccine: mandatory yes or no? Numbers, doubts and controversies
The Government takes time on the vaccination obligation, but if in the coming months the membership is lower than expected, the vaccine could become mandatory for some categories. Here's everything you need to know about the ongoing debate
Vaccine in Italy: doses, calendar, plan. All information
While the political controversy on the possible vaccination obligation for civil servants is mounting, the arrival of new doses is expected for tomorrow - But how many does Italy have available? When will they arrive and from whom? Who will be vaccinated first? Here are all…
Off to Vax Day: in Italy the goal is 10-15 million by April
The first doses of Pfizer-Biontech serum have already arrived in Italy and today the vaccination campaign is starting throughout Europe: getting vaccinated is free and will not be mandatory. Logistics and record security measures. VIDEO - That's who…
EU vaccine: EMA gives the green light to Pfizer serum
The long-awaited go-ahead for the Pfizer vaccine from the European Medicines Agency has finally arrived - Tonight the OK from the Commission - von der Leyen: "Decisive moment" - Shipments from 24 December, the serum will arrive in Rome on 26
Covid: the English variant is in Italy, but the vaccine works
Two cases identified in Rome, a third suspected in Bari - According to scientists, the new version of the coronavirus is not said to be more dangerous than the previous one and at the moment there is no evidence that it is capable of…
Anti-Covid vaccine, it starts on December 27: von der Leyen announces it
"It's Europe's time. On December 27, 28 and 29, vaccination will begin throughout the EU", announced the president of the EU commission, Ursula von der Leyen.
Covid, vaccine from mid-January throughout Europe
The announcement of the emergency commissioner Domenico Arcuri: "The first wave of vaccinations will affect 1,8 million Italians: it will start from doctors and health personnel". The start of the campaign will be on a symbolic date, simultaneously across the continent - A primrose…
Vaccine, Pfizer reassures: "No alarm". News from Astrazeneca
After the two adverse reactions and the mhra's recommendation not to vaccinate anyone with a history of "significant" allergic reactions, Pfizer reassures: the serum is "well tolerated and there are no serious safety concerns" -…
Brexit and vaccines do not shake the stock exchanges but Milan defends 22 thousand
The step forward on Brexit and the green light for the Pfizer vaccine do not wake up the markets awaiting the EU summit on the Mes and the ECB summit after the November rush.
Covid, green light for Pfizer vaccine in the US: "It's safe"
While anti-Covid vaccinations begin in London, in the US the Food and Drug Administration has established that the Pfizer and BioNTech drug "does not raise any particular safety problems". Thursday the final ok for the administration.
Covid vaccine, here is the Italian plan. In the UK, green light to Pfizer
Here is the Italian plan for the distribution of anti-Covid vaccines. We will start with healthcare workers and the elderly - Free serum for everyone, but no obligation - The United Kingdom gives the green light to the Pfizer vaccine, first doses already…
Moderna, vaccine before Christmas: authorizations requested
Phase 3 results indicate that the vaccine has an efficacy of 94,1% and even 100% in severe cases - Applications for authorization from the FDA and EMA today - Thiol soars on the stock market
Re, virologist: "Medicine does not offer absolute certainties but I will get vaccinated"
INTERVIEW WITH MARIA CARLA RE, well-known Bolognese virologist and manager of one of the major public health laboratories in Emilia-Romagna - "I am in favor of vaccines and if the path of persuasion does not give results, they will have to be made mandatory but we cannot delude ourselves that…
Tabacci: "Lombardy healthcare was an excellence with feet of clay"
INTERVIEW WITH BRUNO TABACCI, Member of Parliament elected in Milan, leader of the Democratic Center and former Governor of the Lombardy Region - "It is time for Lombard politics to profoundly rethink its healthcare model, finding a new balance between public and private and…
Vaccines, Moderna-EU agreement for 80 million (plus 80) doses
As anticipated by President von der Leyen, the EU commission signs its sixth contract and expands the vaccine portfolio - Moderna headline on Wall Street - Speranza: "On December 2 I present the vaccine plan"
Bank risk and vaccines animate the Stock Exchange: Creval stands out
Credit Agricole Italia's takeover bid on Creval inflames part of bank stocks - But the imminent arrival of anti-Covid vaccines and the price of oil are also supporting share prices, even if the day is swinging
AstraZeneca vaccine: average efficacy at 70%, but 2 advantages
After Pfizer and Moderna, the first results of the experimentation carried out by AstraZeneca in collaboration with Oxford and the IRBM of Pomezia arrive - Vaccine efficacy varies from 62 to 90%, but two advantages over competitors
The vaccine is advancing: first doses in the US as early as December
The United States is ready to begin mass anti-Covid vaccinations: in May more than 2/3 of the population is expected to be vaccinated - The vaccine fuels market confidence - Dividends arriving at Piazza Affari for…
Vaccine derby: Pfizer re-passes Moderna, waiting for AstraZeneca
It is a battle between the two American giants for the anti Covid vaccine. A new announcement has arrived from Pfizer: "Phase 3 completed, 95% effectiveness. As the derby goes on, a surprise could come from the British AstraZeneca.
Modern vaccine: pre-supply agreement with the EU
A preliminary agreement for 160 million doses - A total of six contracts signed by the EU for the anti Covid-19 vaccine
Stock market, now the vaccine makes rhino stocks run
The discovery of Pfizer and Moderna has triggered a strong turnover in portfolios. In the last 48 hours, the pace and attention to tourism has accelerated. Back to a "new normal"? Surprise on Airbnb. Here are the reasons for the new…
The vaccine pushes the Dow to all-time highs and Tesla enters the S&P
Moderna's anti-Covid vaccine transmits euphoria to the stock exchanges and also relaunches non-performing stocks: Piazza Affari also benefits, which collects a 2% increase in 22 weeks
Piazza Affari at its highest since March, the Moderna vaccine gives wings to the stock exchanges
Sparks on all the Stock Exchanges after the announcement of a vaccine by the American Moderna more effective and simpler than that of Pfizer - Wall Street opens sharply and Piazza Affari closes with an increase of almost 2% ...
Modern vaccine effective at 94,5%: title in rallies and stock exchanges on the shields
A week after Pfizer-BioNtech, Moderna announces the arrival of a vaccine with an efficacy of 94,5% and easily transportable - European stock exchanges run, rally for Moderna stock
In Italy (and not only) recovery hanging from the vaccine
THE HANDS OF THE ECONOMY OF NOVEMBER 2020 - Good and bad news for the economy. The recovery takes the form of one of the last letters of the alphabet. A new relay is underway between the USA and Europe. Asia Felix. Financial markets among surprises…
Vaccine and Biden give the Stock Exchanges a sprint and the Nasdaq restarts
Another positive session on European stock markets while in the USA the recovery of the Nasdaq stands out - Atlantia is heavy in Milan after the arrest of the former CEO Castellucci - Vola Mediaset
The stock market is spinning: high tech is falling, the banks are flying
The possible arrival of the anti-Covid vaccine has changed stock market scenarios and triggered the rotation between sectors, displacing Big Tech and re-evaluating banks and energy
Vaccine since January, but first risk of general lockdown
The Pfizer vaccine should arrive in Italy at the end of January and the AstraZeneca vaccine could also be ready by the same month - The US drug authority has approved the use of Eli Lilly's anti-Covid antibody treatment…
The Pfizer vaccine sends the stock exchanges into orbit: Milan +5,4%
Pfizer's announcement that its anti-Covid vaccine is effective drives stock markets all over the world crazy - Piazza Affari gains 5,4%, driven by the boom of Pirelli (+13%), Unicredit, Leonardo and Eni - In addition to pharma…
The stock exchanges are inflamed: Pfizer has an effective anti-Covid vaccine
Leap of 5% in Milan and strong increases in European price lists after the announcement of the pharmaceutical company: efficacy exceeds 90% and accelerates time to market
Covid scares the stock exchanges, but FCA ok in Milan
Rain of sales on the stock markets: especially heavy Wall Street and the German stock market weighed down by the collapse of SAP (-20%) - The possible EU green light to the FCA-PSA wedding instead gives shine to Elkann's stock
Conte: "We aim for Christmas without lockdown but with the first doses of the vaccine"
The premier explains that the goal is to regain control of the epidemiological curve as soon as possible in order to avoid closures at Christmas, a period in which the first doses of the anti-Covid vaccine could be ready.
Dpcm, semi-lockdown for a month: here are all the news
The new Dpcm kicks in: bars and restaurants will close at 18pm even on Sundays - Stop at cinemas, theatres, gyms, swimming pools - More distance learning in high schools - Compensation for categories penalized by the grip - At Christmas the…
Anti-Covid vaccine, first doses by 2020 for IRBM Pomezia
Interviewed by the Financial Lounge, the president of the Irbm research center in Pomezia Piero Di Lorenzo confirmed Prime Minister Conte's announcement: now it's a matter of weeks or a very few months for the vaccine. The real problem will be that of…
The anti-Covid vaccine slips, new offer for Autostrade
First Johnson & Johnson and then Eli Lilly announce difficulties in testing the anti-Covid vaccine and thus freeze the markets - The international funds Blackstone and Macquarie instead advance a new offer together with CDP to take over 88% of Autostrade
Flu vaccine, an anti-Covid ally. Here because
The flu vaccine cannot replace the one against Covid, which is not yet there. But it is still an important aid to prevention.
Covid, Spallanzani: vaccine perhaps in the spring
An entirely Made in Italy anti-Covid vaccine could be ready as early as spring - This is what emerged from the statements of Marta Branca, during an interview with Poste Italiane news
Vaccine only in 2021, the super-euro scares the ECB
Oil rises, the dollar suffers and the financial markets get nervous - However, the agreement on TikTok is near - At Piazza Affari, all the spotlights are on Tim and Enel, but also on the banks after the Spanish wedding
Pharma and chip, rain billions waiting for the vaccine
The hope of the anti-Covid vaccine supports the stock exchanges on the day when the epidemic reaches its peak worldwide - The restart of AstraZeneca gives confidence - Meanwhile Softbank, under accusation for derivatives on high tech, sells Arm Holdings…
Stock market: the stop to the anti-Covid vaccine does not stop the rebound in price lists
Positive price lists awaiting the ECB and the launch of Wall Street - TLC and utilities are doing well in Milan, industrialists are in the red. Mediaset falls and then recovers - The Treasury places 7 billion BOTs, oil is on the rise
Effervescent bags for vaccine hope: Milan over 2%
The approach of the possible anti-pandemic vaccine excites the stock exchanges: Piazza Affari gains more than 2% with the Ftse Mib which exceeds 20 basis points - New records for S&P and Nasdaq - Oil producers also wake up due to the probable…
Rising stock market: more confidence in the vaccine
Optimism for progress on the Covid-19 vaccine front helps to divert attention from the US-China trade clash - Piazza Affari aims at 20 thousand - Gold falls, the euro rises
Race for the vaccine that doesn't exist: everyone on the hunt for Bingo
China, the USA, Europe and Russia are looking for the treasure that does not yet exist: the economic, financial and political interests of the race for the anti-Covid vaccine are enormous - Moderna, the American biotechnology company which has just signed an agreement with the…
The war on vaccines pushes the stock markets and Tesla makes +13%
According to the German Ifo, the crisis will be completely overcome within 11 months, but in the meantime the challenge on vaccines is good for the stock exchanges - Share split sends Tesla into orbit - Gold recovers
Stock exchange, banks and cars make Milan fly. Gold retreats
With a leap of 2,84% Piazza Affari is today the queen of the stock exchanges thanks to the sharp rise in banks (Banco Bpm in the lead) and the automotive sector - Three reasons behind the new-found market confidence - Profit taking on gold…
Mandatory anti-Covid vaccine or not? Renzi against Conte
While Prime Minister Conte, winking at the No-Vax wing of the grillini, hypothesizes only a voluntary use of the anti-Covid vaccine, Renzi clearly sides with its obligation and starts collecting signatures
The vaccine pushes the stock exchanges, the clashes in Asia hold them back
The winds of war between China and India in the Himalayas are worrying the stock exchanges in Asia, but in the West the hopes of soon arriving at the anti-Coronavirus vaccine are giving breath to the markets - Yesterday Piazza Affari was the most sparkling stock exchange in Europe
Anti-Covid vaccine: the first doses in Italy at the end of the year
The Government has signed a contract with the multinational Astrazeneca together with 3 other European countries to obtain large doses of an anti-Coronavirus vaccine designed by the University of Oxford and on which a company from Pomezia is also working - Whose turn will it be…